The global vascular access device market was valued at USD 6.02 billion in 2024 and is projected to grow from USD 6.49 billion in 2025 to USD 13.65 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 7.7% during the forecast period from 2025 to 2034. This growth is primarily driven by the increasing demand for vascular access in a wide range of medical treatments, advancements in minimally invasive procedures, and a growing patient population requiring long-term intravenous therapies. Vascular access devices (VADs) are essential medical tools used to establish a controlled and reliable route for administering fluids, medications, or nutrition to patients. With the growing prevalence of chronic diseases, cancer, and other health conditions that require intravenous therapy, the vascular access device market is experiencing a surge in demand. Technological advancements in intravenous catheter systems, central venous catheter options, and peripherally inserted ...